← American Frozen Food Institute
FDANonrulemakingFDA-2024-N-3609

Development of an Enhanced Systematic Process for FDA’s Post-Market Assessment of Chemicals in Food; Public Meeting; Request for Comments

RIN
—
Last modified
Mar 11, 2025
Comment window
closed 599d ago
American Frozen Food Institute filings
1

Activity

American Frozen Food Institute filed 1 comment on this docket between Apr 9, 2025 and Apr 9, 2025. 32 other organizations filed here. The comment window closed 599d ago.

What American Frozen Food Institute filed (1)

Apr 9, 2025· Comment from American Frozen Food Institute· FDA-2024-N-3609-62519

The American Frozen Food Institute (AFFI) appreciates the opportunity to comment on the Food and Drug Administration's ("FDA" or "Agency") proposed enhanced systematic process for post-market assessment of chemicals in food. From manufacturers to distributors to suppliers to packagers, AFFI is proud to represent publicly traded and family-owned companies who help produce frozen foods and beverages for today's food service and retail marketplace and serve as economic pillars within their communities. Throughout the U.S., frozen food sales reached $85 billion in the last year, and the industry accounts for 670,000 U.S. jobs. In addition to our members' strong role in economic growth, AFFI members share a commitment to food safety and ensuring consumer confidence in the food supply. AFFI applauds FDA for outlining its proposal to enhance its approach to post-market assessments of chemicals in food. We also appreciate FDA holding the public meeting to solicit stakeholder input, as allowing for public feedback is a critical component to ensuring a transparent process. AFFI believes that a unified approach to post-market assessments will further strengthen consumer confidence in the food supply while minimizing confusion caused by the growing patchwork of state-by-state legislation. As the U.S. authority on food safety and public health, FDA is the appropriate body to be at the head of creating this unified approach. Although we are supportive of FDA's proposed approach, we have identified opportunities for further refinement, additional information, or adjustment. To that end, we propose the following suggestions as FDA works toward implementing the enhanced systematic process: •FDA should incorporate clear and consistent communication and consumer education throughout the post-market assessment process; •FDA's approach to prioritization needs additional clarity and would benefit from additional stakeholder input; •FDA should provide more information on the preliminary review conducted at the triage stage and its criteria for advancing issues to the fit for purpose determination stage; •There are additional opportunities to integrate stakeholder engagement throughout the process; and, •Additional public education on the Generally Recognized as Safe (GRAS) process is needed. We expand on these points in the detailed comments that are attached.

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (32)

See everyone who commented →